SLRN Company Profile and Key Details

NASDAQ : SLRN

Acelyrin

$2.27

Open: 4:00 PM

Not Actively Trading

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Acelyrin, Inc. (SLRN) stock remained unchanged at $2.27 a share on NASDAQ. The stock opened at $2.27, fluctuating between $2.27 to $2.27 during the session.

Stock Snapshot

2.27

Prev. Close

229.17M

Market Cap

2.27

Day Low

-0.8438661710037175

P/E Ratio

-2.69

EPS (TTM)

N/A

Cash Flow per Share

2.27

Open

100.95M

Number of Shares

2.27

Day High

67.8%

Free Float in %

N/A

Book Value

4.06M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 22, 2025	2.27	2.27	2.27	2.27	0
May 21, 2025	2.27	2.27	2.27	2.27	0
May 20, 2025	2.24	2.36	2.20	2.27	4.07M
May 19, 2025	2.21	2.31	2.19	2.23	1.43M
May 16, 2025	2.16	2.26	2.12	2.25	1.14M
May 15, 2025	2.07	2.26	1.95	2.17	2.22M
May 14, 2025	2.08	2.18	1.99	2.05	1.55M
May 13, 2025	2.52	2.56	2.05	2.09	1.9M
May 12, 2025	2.45	2.52	2.36	2.48	793.85K
May 09, 2025	2.47	2.49	2.35	2.36	395.87K
May 08, 2025	2.42	2.49	2.34	2.46	461.18K
May 07, 2025	2.51	2.51	2.37	2.42	513.01K
May 06, 2025	2.52	2.53	2.35	2.42	654.6K
May 05, 2025	2.55	2.64	2.45	2.54	556.22K
May 02, 2025	2.56	2.62	2.46	2.57	579.04K
May 01, 2025	2.50	2.66	2.45	2.58	2.6M
Apr 30, 2025	2.42	2.50	2.38	2.47	366.48K
Apr 29, 2025	2.17	2.49	2.17	2.45	1.03M
Apr 28, 2025	2.16	2.25	2.15	2.18	275.33K
Apr 25, 2025	2.14	2.20	2.08	2.17	474.76K

Contact Details

Agoura Hills, CA 91301

United States

https://www.acelyrin.com 805 730 0360

About Company

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease; and SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. The company was incorporated in 2020 and is headquartered in Agoura Hills, California.

Stock Peers

ARGX

20.69+2.50%

argenx SE$849.04 REGN

4.57+0.61%

Regeneron Pharmaceuticals, Inc.$750.57 UTHR

7.87+1.36%

United Therapeutics Corporation$588.38 MDGL

7.26+1.38%

Madrigal Pharmaceuticals, Inc.$532.02 VRTX

5.55+1.27%

Vertex Pharmaceuticals Incorporated$441.20 PRAX

22.11+6.90%

Praxis Precision Medicines, Inc.$342.50 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-10.47-3.27%

Alnylam Pharmaceuticals, Inc.$309.66 KRYS

10.15+3.84%

Krystal Biotech, Inc.$274.21 ASND

1.53+0.63%

Ascendis Pharma A/S$244.48

Frequently Asked Questions

What is the current Acelyrin, Inc. (SLRN) stock price?

Acelyrin, Inc. (NASDAQ: SLRN) stock price is $2.27 in the last trading session. During the trading session, SLRN stock reached the peak price of $2.27 while $2.27 was the lowest point it dropped to. The percentage change in SLRN stock occurred in the recent session was 0% while the dollar amount for the price change in SLRN stock was $0.00.

SLRN's industry and sector of operation?

The NASDAQ listed SLRN is part of Biotechnology industry that operates in the broader Healthcare sector. Acelyrin, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLRN?

No Data

How SLRN did perform over past 52-week?

SLRN's closing price is 23.04% higher than its 52-week low of $1.85 where as its distance from 52-week high of $7.25 is -68.69%.

How many employees does SLRN have?

Number of SLRN employees currently stands at 83.

Link for SLRN official website?

Official Website of SLRN is: https://www.acelyrin.com

How do I contact SLRN?

SLRN could be contacted at phone 805 730 0360 and can also be accessed through its website. SLRN operates from 4149 Liberty Canyon Road, Agoura Hills, CA 91301, United States.

How many shares of SLRN are traded daily?

SLRN stock volume for the day was 4.06M shares. The average number of SLRN shares traded daily for last 3 months was 997.03K.

What is the market cap of SLRN currently?

The market value of SLRN currently stands at $229.17M with its latest stock price at $2.27 and 100.95M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	83
Beta	1.09
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	83
Beta	1.09
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

SLRN Company Profile and Key Details

Acelyrin

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Shareholding & Insider Activity

Valuation Metrics